Dr. Thomas E. Angelini is an associate professor in the department of Mechanical and Aerospace Engineering at the University of Florida. In 2005, Dr. Angelini received his PhD in physics from the University of Illinois, studying self-assembly of proteins, lipids, DNA and viruses, using techniques like small angle x-ray scattering (SAXS), cryo-electron microscopy, and confocal microscopy.
Dr. Bhumiratana has over a decade of experience in biological research, and biomedical engineering. His work has spanned from research in protein engineering, the shrimp genome project, eye tissues, and cell culturing.
Richard Billo was appointed Associate Vice President for Research in 2013, where he manages Notre Dame Research Development. In addition to this role, he is a Professor in the Department of Computer Science and Engineering, with research interests in advanced manufacturing and information systems.
Marcie Black is CEO and co-founder of Advanced Silicon Group. Dr. Black brings to the company expertise in building strong teams, managing development projects, patents, IP strategy, encouraging a healthy company culture, cost modeling, and running a startup.
Ryan Downs is a Vice President with MPR Associates, Inc. Mr. Downs joined MPR in 1997 and has since led technology and product development projects for medical device companies, pharmaceutical companies, large hospital systems, US military and other Federal Government agencies.
Dr. Francis is a proven biotechnology professional with a passion and prowess for translational science & regenerative medicine. Dr. Francis is a cultivated communicator, educator and energizer offering 20 years of diverse R&D and leadership experience spanning cardiovascular, orthopedic, spine, craniofacial and sports medicine indications.
Steve Geelhood is the Business Director at Blood Cell Storage, Inc. (BCSI). He is also the inventor of BCSI's noninvasive fluorescent pH detection technology.
Paul Goodwin is the Science Director for GE Healthcare’s Life Sciences business, located in the Seattle, WA area. Paul received his Bachelor’s degree in Biology from the University of California, San Diego and continued his education in the Department of Physiology and Biophysics at the University of Washington, Seattle, WA where he obtained a Master’s degree.
Michael Graffeo is CEO and Co-founder of FluidForm, a leader in 3D bioprinting of cells and biologic scaffolds for engineering functional human tissues. He is an accomplished Senior Executive, with more than 20 years of success across the medical device, pharmaceutical, and biotechnology industries.
Kevin Hannigan oversees all aspects of ACC and Lab Owl operations. He defines business development strategy and company initiatives for customer solutions, as well as sets goals for ACC’s product development and market focus. Kevin has a long history managing large multi-discipline projects and adopting new industries and technologies into ACC’s portfolio of offerings.
Esmaiel Jabbari is a Tenured Full Professor of Chemical and Biomedical Engineering, Adjunct Professor of Orthopedic Surgery, and Director of Tissue Engineering, Drug Delivery, and Biomimetic Materials at University of South Carolina. He is also the Founder and President of Bioinspired Solutions LLC for the purpose of commercialization of bioinspired cell culture systems for tissue regeneration to the healthcare market.
Dr. Adam Jakus is currently the co-founder and Chief Technology of Dimension Inx LLC, a start-up developing transformative advanced manufacturing materials and processes for medical and non-medical spaces. Adam received his BS and MS degrees in Materials Science and Engineering from The Georgia Institute of Technology, where he worked on: The experimental and computational design and development of new metal- and ceramic-based energetic materials; ballistic projectile-material interaction simulation and experiments; materials design for thermochemical nano-lithography; quantum dot design and synthesis; and more.
Originally trained as a molecular biochemist (U. Copenhagen), Dr. Jensen is a molecular developmental biologist with particular expertise in development of pancreas, stomach, lung and gut, and has published >60 papers in international journals including Nature Genetics, PNAS, Developmental Biology, Development, Gastroenterology, and more. He is the E. J. Brandon Endowed professor in Diabetes Research at the Cleveland Clinic.
Stephen Kennedy is the Chief Operating Officer and Executive VP of Histogenics. Mr. Kennedy joined Histogenics in 2013 with responsibilities over manufacturing, technology development and quality operations related to clinical development of its flagship product NeoCart, which is a tissue engineered autologous cartilage product.
John Killam is a multifaceted, innovative leader with extensive experience in operations management, manufacturing engineering and optimization, quality management, business development, manufacturing operations, R&D, cost analysis and strategic production planning. John has thirty years experience working for fortune 200 manufacturing companies and is certified in the Toyota Production system by a Shingijutsu Sensei.
Dr. Mark Kline serves as the technical and operating lead for X-Therma Inc., a company working to improve the storage and transport of regenerative medicines, where he oversees the management of government support, among other roles. Dr. Kline has been continuously involved in research at the interplay of chemistry and biology and brings technical expertise to the ARMI BioFabUSA community in the areas of supramolecular interactions, peptidomimetic and polymer systems, and the design and characterization of supramolecular nanostructures.
Dr. Mrignayani Kotecha, PhD, is a founding member and the CEO of O2M Technologies, LLC since its inception in Feb 2017. The company was formed with the purpose of bringing pulse electron paramagnetic resonance oxygen imaging (EPROI) to the market.
Harry’s career has centered on civilian and military medicine with over 18 years of product development, operations and strategy-related experience as a VP/C-level executive and entrepreneur in biotechnology. He has a strong track record of leading and supervising development efforts for biologics, cellular therapies and tissue-engineered products.
Darren Nolen is the founder of Nolen Ortho and the inventor of the controlled activation technology enabling their products. Growing up on the wind-sept prairies, he obtained a degree in Mechanical Engineering at the University of Kansas.
Jeff Ross, Ph.D. brings more than 20 years of biomedical research, management and regulatory experience in regenerative medicine, biologics, and medical devices to Miromatrix including concept development, preclinical, clinical, manufacturing, and commercialization. He has held various technical and management positions at Guidant, Athersys and SurModics.
Sangya S. Varma, PhD is a scientist: an inventor, an innovator, an educator and a leader. She is the COO of NJ Center for Biomaterials, a multidisciplinary center of excellence for Tissue Engineering, Regenerative Medicine, and Drug Delivery – that spans academia (30+ National and International Institutions), industry (60+) and government. She directs the implementation and utilization of $75 million and manages all of the operations at NJCBM including sponsored programs – federal and industry.
Dr. Young has more than 25 years of extensive expertise in the area of medical device design and materials development. Previous industrial experience includes employment at American Cyanamid, Shell Chemical Company, and WL Gore.